Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed optimally titrated pramipexole, with significantly reduced sleep-related and dopaminergic side effectsData analysis also confirmed patients treated with P2B001 developed significantly less new-onset excessive daytime sleepiness when compared to marketed pramipexole
Pharma Two B to Present Additional Positi... - Cure Parkinson's
Pharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual Meeting
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
New Clinical Study regarding Mucuna Pruriens
New clinical study, 7-5-2017, with favorable results:...
Mucuna Pruriens in Parkinson's disease, dosages and effects, A double-blind, randomized, controlled, crossover human study (2017)
Mucuna pruriens in Parkinson disease. A double-blind, randomized, controlled, crossover study...
Melatonin For Covid-19 (Part 2 / 07-08-2021)
In case you missed part 1, here is a link to it:...
Can Levodopa Contribute to Gut Dysbiosis via Increased Gut Inflammation and More Dysbiosis? The Study Below Suggests It Can
Gut dysbiosis seems to be very prevalent in people with PD and many other diseases or health issues...
billiards
i have come across in YOU TUBE a product under BestMade Natural Homeopathy Remedy for Parkinson's...